Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-12 | Ms. Abbie TidmoreSenior MD & Chief Revenue Officer | -484,00 | 5,75k | Sale to Issuer | 11,89 | 24,08k | -1,97% |
| 2026-03-12 | Mr. Derek W. StarkSenior MD, Chief Legal Officer & Secretary | -931,00 | 11,07k | Sale to Issuer | 11,89 | 62,54k | -1,47% |
| 2026-03-12 | Mr. Douglas Edward JonesPresident, Chief Mortgage Banking Officer & Director | -2,96k | 35,19k | Sale to Issuer | 11,89 | 37,90k | -7,24% |
| 2026-03-12 | Mr. Daniel Stanley PerottiSenior MD & CFO | -2,66k | 31,60k | Sale to Issuer | 11,89 | 152,93k | -1,71% |
| 2026-03-12 | Mr. David A. SpectorChairman of the Board & CEO | -5,26k | 62,48k | Sale to Issuer | 11,89 | 315,46k | -1,64% |
| 2026-02-28 | Mr. James FolletteSenior MD & Chief Digital Officer | -586,00 | 7,18k | Sale to Issuer | 12,26 | 21,53k | -2,65% |
| 2026-02-28 | Mr. Douglas Edward JonesPresident, Chief Mortgage Banking Officer & Director | -2,72k | 33,33k | Sale to Issuer | 12,26 | 34,60k | -7,29% |
| 2026-02-28 | Mr. Derek W. StarkSenior MD, Chief Legal Officer & Secretary | -1,03k | 12,58k | Sale to Issuer | 12,26 | 63,47k | -1,59% |
| 2026-02-28 | Mr. Daniel Stanley PerottiSenior MD & CFO | -2,93k | 35,91k | Sale to Issuer | 12,26 | 155,59k | -1,85% |
| 2026-02-28 | Mr. David A. SpectorChairman of the Board & CEO | -5,79k | 71,00k | Sale to Issuer | 12,26 | 310,27k | -1,83% |
| 2026-02-24 | Mr. Mark Evan ElbaumSenior MD & Chief Capital Markets Officer | -1,31k | 15,97k | Sale to Issuer | 12,15 | 3,75k | -25,94% |
| 2026-02-24 | Ms. Abbie TidmoreSenior MD & Chief Revenue Officer | -468,00 | 5,69k | Sale to Issuer | 12,15 | 23,25k | -1,97% |
| 2026-02-24 | Mr. Derek W. StarkSenior MD, Chief Legal Officer & Secretary | -954,00 | 11,59k | Sale to Issuer | 12,15 | 64,50k | -1,46% |
| 2026-02-24 | Mr. Daniel Stanley PerottiSenior MD & CFO | -1,91k | 23,18k | Sale to Issuer | 12,15 | 158,52k | -1,19% |
| 2026-02-24 | Mr. Douglas Edward JonesPresident, Chief Mortgage Banking Officer & Director | -4,02k | 48,81k | Sale to Issuer | 12,15 | 31,56k | -11,29% |
| 2026-02-24 | Mr. James FolletteSenior MD & Chief Digital Officer | -382,00 | 4,64k | Sale to Issuer | 12,15 | 22,11k | -1,70% |
| 2026-02-24 | Mr. David A. SpectorChairman of the Board & CEO | -7,49k | 90,97k | Sale to Issuer | 12,15 | 304,55k | -2,40% |
| 2026-02-23 | Mr. Mark Evan ElbaumSenior MD & Chief Capital Markets Officer | 1,88k | 0,00 | Derivative Exercise and Retained Stock | - | 1,88k | - |
| 2026-02-23 | Mr. Mark Evan ElbaumSenior MD & Chief Capital Markets Officer | -1,21k | 14,85k | Derivative Exercise and Sale | 12,29 | 1,88k | - |
| 2026-02-23 | Ms. Abbie TidmoreSenior MD & Chief Revenue Officer | 2,51k | 0,00 | Derivative Exercise and Retained Stock | - | 21,60k | 13,15% |
| 2026-02-23 | Ms. Abbie TidmoreSenior MD & Chief Revenue Officer | -809,00 | 9,94k | Derivative Exercise and Sale | 12,29 | 21,60k | - |
| 2026-02-23 | Mr. David A. SpectorChairman of the Board & CEO | 16,41k | 0,00 | Derivative Exercise and Retained Stock | - | 297,15k | 5,85% |
| 2026-02-23 | Mr. David A. SpectorChairman of the Board & CEO | -19,23k | 236,35k | Derivative Exercise and Sale | 12,29 | 297,15k | - |
| 2026-02-23 | Mr. James FolletteSenior MD & Chief Digital Officer | 2,02k | 0,00 | Derivative Exercise and Retained Stock | - | 12,36k | 19,52% |
| 2026-02-23 | Mr. James FolletteSenior MD & Chief Digital Officer | -1,13k | 13,91k | Derivative Exercise and Sale | 12,29 | 12,36k | - |
| 2026-02-23 | Mr. Douglas Edward JonesPresident, Chief Mortgage Banking Officer & Director | 9,75k | 0,00 | Derivative Exercise and Retained Stock | - | 27,07k | 56,32% |
| 2026-02-23 | Mr. Douglas Edward JonesPresident, Chief Mortgage Banking Officer & Director | -10,11k | 158,14k | Derivative Exercise and Sale | 12,29 - 23,29 | 27,07k | - |
| 2026-02-23 | Mr. Daniel Stanley PerottiSenior MD & CFO | 10,11k | 0,00 | Derivative Exercise and Retained Stock | - | 109,76k | 10,14% |
| 2026-02-23 | Mr. Daniel Stanley PerottiSenior MD & CFO | -5,66k | 69,54k | Derivative Exercise and Sale | 12,29 | 109,76k | - |
| 2026-02-23 | Mr. Derek W. StarkSenior MD, Chief Legal Officer & Secretary | 4,03k | 0,00 | Derivative Exercise and Retained Stock | - | 40,70k | 10,99% |
| 2026-02-23 | Mr. Derek W. StarkSenior MD, Chief Legal Officer & Secretary | -2,26k | 27,75k | Derivative Exercise and Sale | 12,29 | 40,70k | - |
| 2026-01-23 | Ms. Catherine A. LynchInitié | 1,45k | 19,21k | Achat | 13,20 - 13,28 | 49,85k | 3,00% |
| 2025-11-17 | Mr. David A. SpectorChairman of the Board & CEO | 10,00k | 124,00k | Achat | 12,40 | 280,74k | 3,69% |
| 2025-10-24 | Ms. Catherine A. LynchInitié | 1,47k | 18,62k | Achat | 12,67 | 48,40k | 3,13% |
| 2025-09-22 | Ms. Catherine A. LynchInitié | 2,82k | 33,93k | Achat | 12,02 | 46,92k | 6,40% |
| 2025-07-25 | Ms. Catherine A. LynchInitié | 1,37k | 16,95k | Achat | 12,30 - 12,56 | 44,09k | 3,20% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
